Astec LifeSciences Limited Stock Price Today (NSE: ASTEC)
Fundamental Score
Astec LifeSciences Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Astec LifeSciences Limited share price today is ₹715.80, down 5.94% on NSE/BSE as of 10 September 2026. Astec LifeSciences Limited (ASTEC) is a Small-cap company in the Pesticides & Agrochemicals sector with a market capitalisation of ₹1.60K (Cr). The 52-week high for ASTEC share price is ₹941.75 and the 52-week low is ₹513.40. The company has a Return on Equity (ROE) of -25.88% and a debt-to-equity ratio of 1.15.
Astec LifeSciences Limited Share Price Chart — NSE/BSE Historical Performance
Astec LifeSciences Limited share price chart: 6.79% return over the past month. 52-week high ₹941.75, 52-week low ₹513.40.
Astec LifeSciences Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹751.00 | ₹751.00 | ₹693.40 | ₹715.80 | 5.24L (Cr) | |
| ₹691.00 | ₹779.35 | ₹690.00 | ₹761.00 | 53.57L (Cr) | |
| ₹551.20 | ₹662.80 | ₹551.20 | ₹662.80 | 12.71L (Cr) | |
| ₹555.00 | ₹559.30 | ₹540.00 | ₹552.35 | 41.08K (Cr) | |
| ₹581.80 | ₹581.80 | ₹552.10 | ₹554.45 | 43.91K (Cr) | |
| ₹571.10 | ₹581.00 | ₹570.10 | ₹573.25 | 10.62K (Cr) | |
| ₹556.95 | ₹584.90 | ₹553.05 | ₹572.55 | 37.65K (Cr) | |
| ₹560.00 | ₹576.60 | ₹555.30 | ₹562.40 | 22.63K (Cr) | |
| ₹581.45 | ₹585.00 | ₹556.00 | ₹560.70 | 52.14K (Cr) | |
| ₹589.00 | ₹593.95 | ₹572.00 | ₹581.45 | 25.13K (Cr) |
Astec LifeSciences Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹560.00 | ₹779.35 | ₹540.00 | ₹715.80 | +27.82% | |
| ₹645.00 | ₹663.80 | ₹550.00 | ₹560.70 | -13.07% | |
| ₹705.00 | ₹749.00 | ₹621.10 | ₹655.35 | -7.04% | |
| ₹769.70 | ₹848.85 | ₹703.40 | ₹711.25 | -7.59% | |
| ₹694.70 | ₹850.00 | ₹647.95 | ₹770.95 | +10.98% | |
| ₹564.00 | ₹769.70 | ₹534.00 | ₹694.70 | +23.17% | |
| ₹616.00 | ₹649.00 | ₹513.40 | ₹540.60 | -12.24% | |
| ₹571.00 | ₹682.00 | ₹562.40 | ₹623.70 | +9.23% | |
| ₹715.00 | ₹729.00 | ₹557.00 | ₹575.00 | -19.58% | |
| ₹826.05 | ₹867.80 | ₹697.10 | ₹705.00 | -14.65% | |
| ₹669.00 | ₹941.75 | ₹607.05 | ₹837.90 | +25.25% | |
| ₹796.65 | ₹847.00 | ₹655.00 | ₹660.05 | -17.15% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Astec LifeSciences Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Astec LifeSciences Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ASTEC across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (72.42%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
12 factors identified
Below-Average Return on Equity (-25.88%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-9.70%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.98%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-43.35%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-8.25%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-4.18% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Elevated Debt Levels (D/E: 1.15)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (-1.35x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Liquidity Concerns (Current Ratio: 0.89)
Observation: Current assets may not adequately cover short-term liabilities.
Analysis: Current ratio <1.0 raises working capital concerns.
Negative Free Cash Flow (₹-364.72 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 3.36%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Astec LifeSciences Limited vs Pesticides & Agrochemicals Peers
Peer Comparison - Pesticides & Agrochemicals
Compare Astec LifeSciences Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Astec LifeSciences LimitedAstec LifeScien...Selected✓ ASTEC • 533138 | 23.2/100 | ₹715.80₹716 | ₹1595.00₹1595.00 | — — | -25.88%Poor -25.88% Poor | -9.70%Poor -9.70% Poor | 1.15Average 1.1 Average | — — | -4.18%Poor -4.18% Poor | 0.00% |
UPL LimitedUPL Limited... UPL • 512070 | 23.9/100 | ₹576.15₹576 | ₹48684.68₹48684.68 | 23.88Average 23.9 Average | 6.01%Poor 6.01% Poor | 11.26%Average 11.26% Average | 0.64Good 0.6 Good | -7.71%Poor -7.71% Poor | 6.02%Good 6.02% Good | 1.00% |
PI Industries LimitedPI Industries L... PIIND • 523642 | 46.8/100 | ₹2385.00₹2385 | ₹36252.00₹36252.00 | 31.05Average 31.1 Average | 12.16%Average 12.16% Average | 15.37%Good 15.37% Good | 0.02Excellent 0.0 Excellent | 9.98%Good 9.98% Good | 7.96%Good 7.96% Good | 0.61% |
Sumitomo Chemical India LimitedSumitomo Chemic... SUMICHEM • 542920 | 50.3/100 | ₹479.50₹480 | ₹23934.05₹23934.05 | 41.30Average 41.3 Average | 17.26%Good 17.26% Good | 22.61%Excellent 22.61% Excellent | 0.00Excellent 0.0 Excellent | 9.93%Good 9.93% Good | 4.13%Average 4.13% Average | 0.24% |
Bayer Cropscience LimitedBayer Cropscien... BAYERCROP • 506285 | 52.1/100 | ₹3956.40₹3956 | ₹18487.02₹18487.02 | 26.82Average 26.8 Average | 23.70%Excellent 23.70% Excellent | 29.14%Excellent 29.14% Excellent | 0.03Excellent 0.0 Excellent | 7.24%Good 7.24% Good | 5.90%Good 5.90% Good | 3.04% |
Sharda Cropchem LimitedSharda Cropchem... SHARDACROP • 538666 | 80.7/100 | ₹782.65₹783 | ₹7061.11₹7061.11 | 11.28Average 11.3 Average | 24.16%Excellent 24.16% Excellent | 27.95%Excellent 27.95% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 17.07%Excellent 17.07% Excellent | 0.99% |
Dhanuka Agritech LimitedDhanuka Agritec... DHANUKA • 507717 | 61.8/100 | ₹982.85₹983 | ₹4381.40₹4381.40 | 16.53Average 16.5 Average | 18.62%Good 18.62% Good | 24.02%Excellent 24.02% Excellent | 0.00Excellent 0.0 Excellent | 6.41%Good 6.41% Good | 7.80%Good 7.80% Good | 0.19% |
NACL Industries LimitedNACL Industries... NACLIND • 524709 | 34.7/100 | ₹166.08₹166 | ₹3891.25₹3891.25 | 325.65Average 325.6 Average | 0.82%Poor 0.82% Poor | 8.98%Poor 8.98% Poor | 0.44Excellent 0.4 Excellent | -23.85%Poor -23.85% Poor | 5.87%Good 5.87% Good | 0.00% |
Rallis India LimitedRallis India Li... RALLIS • 500355 | 43.5/100 | ₹204.00₹204 | ₹3876.00₹3876.00 | 18.60Average 18.6 Average | 9.32%Poor 9.32% Poor | 12.60%Average 12.60% Average | 0.00Excellent 0.0 Excellent | -4.24%Poor -4.24% Poor | 3.58%Average 3.58% Average | 1.26% |
Bhagiradha Chemicals & Industries LimitedBhagiradha Chem... BHAGCHEM • 531719 | 27.7/100 | ₹264.50₹265 | ₹3429.75₹3429.75 | 124.76Average 124.8 Average | 2.63%Poor 2.63% Poor | 4.78%Poor 4.78% Poor | 0.33Excellent 0.3 Excellent | -4.35%Poor -4.35% Poor | 11.01%Good 11.01% Good | 0.05% |
Bharat Rasayan LimitedBharat Rasayan ... BHARATRAS • 590021 | 48.8/100 | ₹1170.00₹1170 | ₹1944.66₹1944.66 | 8.57Average 8.6 Average | 0.00%Poor 0.00% Poor | 15.97%Good 15.97% Good | 0.00Excellent 0.0 Excellent | -1.03%Poor -1.03% Poor | 2.61%Average 2.61% Average | 0.03% |
Top Pesticides & Agrochemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- UPL Limited share price48684.68 Cr
- PI Industries Limited share price36252.00 Cr
- Sumitomo Chemical India Limited share price23934.05 Cr
- Bayer Cropscience Limited share price18487.02 Cr
- Sharda Cropchem Limited share price7061.11 Cr
Astec LifeSciences Limited PE Ratio History
Historical price-to-earnings ratio for ASTEC — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹12.94 | ₹1095.25 | 84.6x |
| FY 2022 | ₹45.50 | ₹1751.00 | 38.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Astec LifeSciences Limited Dividend History
Annual cash dividends paid by ASTEC — dividend yield N/A
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹2.94 Cr |
| FY 2023 | ₹2.94 Cr |
| FY 2022 | ₹2.94 Cr |
| FY 2021 | ₹2.94 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Astec LifeSciences Limited Quarterly Performance
Latest quarterly metrics for ASTEC — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-8.25%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-43.35%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-4.18%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Astec LifeSciences Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ASTEC — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Astec LifeSciences Limited Financial Statements
Annual income statement, balance sheet and cash flow for Astec LifeSciences Limited (ASTEC) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Astec LifeSciences Limited
About ASTEC (Astec LifeSciences Limited)
Astec LifeSciences Ltd is a pivotal player in the agrochemical sector, specializing in the meticulous creation of essential ingredients that underpin modern agriculture. The compan...y's expertise lies in synthesizing active ingredients for crop protection products, primarily focusing on triazole fungicides. These compounds are instrumental in safeguarding a wide spectrum of crops from fungal diseases, contributing to improved yields and reduced post-harvest losses. Astec meticulously engineers its products to meet the stringent demands of the agricultural industry, ensuring both efficacy and environmental responsibility. Through constant innovation and a commitment to sustainable practices, Astec LifeSciences strengthens its position as a reliable supplier for global crop protection companies. Beyond fungicides, Astec LifeSciences also produces a range of specialized chemical intermediates vital to the pharmaceutical industry. These intermediates serve as key building blocks for complex drug molecules, showcasing the company's versatile chemistry capabilities. This dual focus on agrochemicals and pharmaceutical intermediates positions Astec as a significant contributor to both food security and human health. The company invests significantly in research and development, constantly seeking to refine its processes and develop novel compounds that address emerging challenges in both agricultural and pharmaceutical sectors. Astec understands the importance of quality and precision in its manufacturing processes, assuring that its outputs adhere to the highest industry standards. Operating within India, Astec LifeSciences leverages its local expertise and infrastructure to serve a global clientele. The company strategically cultivates its strong relationships with both domestic and international clients. Astec's commitment to reliable supply chains, combined with a deep understanding of the agrochemical and pharmaceutical markets, makes it a trusted partner for organizations seeking high-quality chemical solutions. With its blend of scientific expertise, manufacturing proficiency, and a focus on responsible business practices, Astec LifeSciences contributes significantly to advancing agricultural productivity and pharmaceutical innovation.
Company Details
Key Leadership
ASTEC Share Price: Frequently Asked Questions
What is the current share price of Astec LifeSciences Limited?
Astec LifeSciences Limited (ASTEC) trades at ₹715.80 on NSE and BSE. Market cap ₹1.60K (Cr). Educational data only.
What is the P/E ratio of Astec LifeSciences Limited?
Astec LifeSciences Limited has a P/E of N/Ax vs industry average 22.96x.
What is the Bull Run score for Astec LifeSciences Limited?
Astec LifeSciences Limited has a Bull Run score of 23.2/100 based on 25+ financial parameters.
Does Astec LifeSciences Limited pay dividends?
Astec LifeSciences Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Astec LifeSciences Limited?
Astec LifeSciences Limited has ROE of -25.88%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Astec LifeSciences Limited?
Astec LifeSciences Limited has debt-to-equity of 1.15.
Is Astec LifeSciences Limited a good investment?
Bull Run gives Astec LifeSciences Limited a score of 23.2/100. This is not investment advice — consult a SEBI-registered advisor.